Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3258168rdf:typepubmed:Citationlld:pubmed
pubmed-article:3258168lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:3258168lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3258168lifeskim:mentionsumls-concept:C0591466lld:lifeskim
pubmed-article:3258168lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:3258168lifeskim:mentionsumls-concept:C0057941lld:lifeskim
pubmed-article:3258168pubmed:issue3lld:pubmed
pubmed-article:3258168pubmed:dateCreated1988-5-12lld:pubmed
pubmed-article:3258168pubmed:abstractTextThe influence of ethacizin (a diethylamine analog of ethmozine) (1.10(-7)-1.10(-6) g/ml) upon the phase-dependent chronotropic parasympathetic effects was studied on the perfused frog heart. The vagolytic influence of ethacizin (5.10(-7) and 1.10(-6) g/ml) was detected; the concentration of 1.10(-7) g/ml was found ineffective. The vagolytic effect consisted of a decreased maximum of phase-dependent effect, reduced latency and time required for the manifestation of the maximum increase. The period of inhibitory vagal stimulus effectiveness did not change significantly.lld:pubmed
pubmed-article:3258168pubmed:languageruslld:pubmed
pubmed-article:3258168pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3258168pubmed:citationSubsetIMlld:pubmed
pubmed-article:3258168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3258168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3258168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3258168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3258168pubmed:statusMEDLINElld:pubmed
pubmed-article:3258168pubmed:monthMarlld:pubmed
pubmed-article:3258168pubmed:issn0365-9615lld:pubmed
pubmed-article:3258168pubmed:authorpubmed-author:KopylovaG NGNlld:pubmed
pubmed-article:3258168pubmed:authorpubmed-author:KrupnovaE PEPlld:pubmed
pubmed-article:3258168pubmed:issnTypePrintlld:pubmed
pubmed-article:3258168pubmed:volume105lld:pubmed
pubmed-article:3258168pubmed:ownerNLMlld:pubmed
pubmed-article:3258168pubmed:authorsCompleteYlld:pubmed
pubmed-article:3258168pubmed:pagination298-300lld:pubmed
pubmed-article:3258168pubmed:dateRevised2008-10-8lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:meshHeadingpubmed-meshheading:3258168-...lld:pubmed
pubmed-article:3258168pubmed:year1988lld:pubmed
pubmed-article:3258168pubmed:articleTitle[Influence of ethacizin (the diethyl analog of ethmozine) on phase-dependent parasympathetic effects on the heart].lld:pubmed
pubmed-article:3258168pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3258168pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3258168pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3258168pubmed:publicationTypeEnglish Abstractlld:pubmed